Bio Usawa appoints former Pfizer chief medical officer Dr. Aida Habtezion to board of directors
By
GlobeNewswire
Pure flour-power. Hearty enough to carry you through lunch.
Summary
Bio Usawa, a biotechnology company focused on expanding access to high-quality biologic medicines in Africa and other underserved regions, has appointed Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors. Dr. Habtezion brings extensive experience in global drug development and regulatory strategy, having previously led Pfizer's worldwide medical and clinical operations. Her appointment is expected to strengthen Bio Usawa's mission of making biologic treatments more accessible and affordable in emerging markets.
Key quotes
· 3 pulledDr. Aida Habtezion's deep expertise in global drug development and regulatory strategy will be invaluable as we work to expand access to biologic medicines across Africa and other underserved regions.
I am honored to join Bio Usawa's Board of Directors and contribute to a mission that aligns with my lifelong commitment to improving global health equity.
This appointment marks a significant milestone in our journey to transform the biotechnology landscape in emerging markets.
You might also wanna read
Scientists removed from ADA conference for sharing editorial critical of Trump administration's science policies
Five leading scientists, including the editor-in-chief of Diabetes Care and a former ADA president, were ejected from the American Diabetes
arstechnica.com·8d agoFDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ
arstechnica.com·7mo ago
CDC Director Susan Monarez Fired by White House After Refusing to Resign; Four Top Officials Quit
The White House fired CDC Director Susan Monarez after she refused to resign, with four other top CDC officials also quitting. The leadershi
Undisclosed Deaths in the Pfizer mRNA Covid-19 Vaccine Trial [pdf]

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
DNI Gabbard Reveals Evidence of U.S.-Funded Global Biolab Network Across 30 Countries
DNI Tulsi Gabbard has released evidence revealing a U.S. taxpayer-funded global biolab program involving more than 120 labs across over 30 c
